Scholarlink

<p>Diabetic kidney disease (DKD), which lacks effective treatment, has become the leading cause of end-stage renal disease. Apoptosis of podocytes, as a vital mode of cell injury, plays an important role in the progression of DKD. MicroRNA-21 (miR-21) and Forkhead transcription Factor O1 (FoxO1) have been revealed to act in DKD, but the mechanisms remain elusive. Here, we investigated the special regulatory mechanism by which miR-21 activates FoxO1 in mouse podocytes induced by high glucose (HG). In vitro, after exposure to HG, podocyte apoptosis, miR-21, HDAC4, FoxO1/acetylate-FoxO1/phosphorylate-FoxO1, Bcl-2, and nephrin were examined. Then, we evaluated the vital effect of miR-21 in regulating podocyte apoptosis and identified the critical activator of FoxO1 by overexpression or inhibition of miR-21/HDAC4 via adenoviral transfer. The results showed that HG increased podocyte apoptosis, elevated the expression of miR-21, HDAC4, acetylate-FoxO1, and FoxO1, and reduced the expression of Bcl-2 and nephrin. In addition, overexpression or inhibition of miR-21 could affect the levels of HDAC4, acetylated FoxO1, FoxO1, Bcl-2, and nephrin. Finally, overexpression of HDAC4 decreased the acetylation of FoxO1 while increasing the phosphorylation of FoxO1, which resulted in a decline in Bcl-2 and nephrin. Therefore, these data indicated that miR-21/FoxO1 was a key pathway in regulating podocyte apoptosis under HG conditions. Furthermore, phosphorylation rather than acetylation was the critical activator of FoxO1.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MicroRNA21/HDAC4 mediates podocyte apoptosis under high glucose conditions by regulating the activation of FoxO1

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月3日

查看全文
  • Lanjun Fu,
  • Nan Yang,
  • Juan Jin,
  • Hongbo Chen,
  • Junfen Fan,
  • Qiang He,
  • Qingqing Ye

摘要

Diabetic kidney disease (DKD), which lacks effective treatment, has become the leading cause of end-stage renal disease. Apoptosis of podocytes, as a vital mode of cell injury, plays an important role in the progression of DKD. MicroRNA-21 (miR-21) and Forkhead transcription Factor O1 (FoxO1) have been revealed to act in DKD, but the mechanisms remain elusive. Here, we investigated the special regulatory mechanism by which miR-21 activates FoxO1 in mouse podocytes induced by high glucose (HG). In vitro, after exposure to HG, podocyte apoptosis, miR-21, HDAC4, FoxO1/acetylate-FoxO1/phosphorylate-FoxO1, Bcl-2, and nephrin were examined. Then, we evaluated the vital effect of miR-21 in regulating podocyte apoptosis and identified the critical activator of FoxO1 by overexpression or inhibition of miR-21/HDAC4 via adenoviral transfer. The results showed that HG increased podocyte apoptosis, elevated the expression of miR-21, HDAC4, acetylate-FoxO1, and FoxO1, and reduced the expression of Bcl-2 and nephrin. In addition, overexpression or inhibition of miR-21 could affect the levels of HDAC4, acetylated FoxO1, FoxO1, Bcl-2, and nephrin. Finally, overexpression of HDAC4 decreased the acetylation of FoxO1 while increasing the phosphorylation of FoxO1, which resulted in a decline in Bcl-2 and nephrin. Therefore, these data indicated that miR-21/FoxO1 was a key pathway in regulating podocyte apoptosis under HG conditions. Furthermore, phosphorylation rather than acetylation was the critical activator of FoxO1.